Regulus Therapeutics Valuation
| RGLSDelisted Stock | USD 8.16 0.01 0.12% |
At this time, the company appears to be overvalued. Regulus Therapeutics holds a recent Real Value of $5.57 per share. The prevailing price of the company is $8.16. Our model determines the value of Regulus Therapeutics from analyzing the company fundamentals such as Shares Owned By Institutions of 82.87 %, shares outstanding of 69.23 M, and Return On Equity of -0.54 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Regulus Therapeutics' price fluctuation is very steady at this time. Calculation of the real value of Regulus Therapeutics is based on 3 months time horizon. Increasing Regulus Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Regulus stock is determined by what a typical buyer is willing to pay for full or partial control of Regulus Therapeutics. Since Regulus Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Regulus Stock. However, Regulus Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.16 | Real 5.57 | Hype 8.16 |
The intrinsic value of Regulus Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Regulus Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Regulus Therapeutics helps investors to forecast how Regulus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Regulus Therapeutics more accurately as focusing exclusively on Regulus Therapeutics' fundamentals will not take into account other important factors: About Regulus Therapeutics Valuation
The delisted stock valuation mechanism determines Regulus Therapeutics' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Regulus Therapeutics based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Regulus Therapeutics. We calculate exposure to Regulus Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Regulus Therapeutics's related companies.Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California. Regulus Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 26 people.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Regulus Stock
If you are still planning to invest in Regulus Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Regulus Therapeutics' history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |